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ACTIVATED cholesterol-laden macrophages in atheroscle-
rotic lesions are believed to influence the progression of
this disease. The induction of nitric oxide synthase
(iNOS) activity was investigated in control and choles-
terol-laden J774 macrophages, obtained by pre-incuba-
tion with oxidized or acetylated low density lipoproteins
(oxLDL, acLDL). Loading with oxLDL caused a small in-
duction ofNOS activity in unstimulated cells, as indicated
by nitrite and citrulline accumulation in the supernatant.
However, it suppressed the tNOS activity resulting from
stimulation of the cells with lipopolysaccharide with or
without interferon-T. AcLDL had no inhibitory effect, in-
dicating that cholesterol accumulation as such was not
responsible. Since the induction of NOS in macrophages
is inhibited by glucocorticoids, the possibility that a
glucocorticoid-like factor, formed during oxidation of
LDL, may cause the inhibition, was investigated. How-
ever, addition of the glucocorticoid receptor antagonist
mifepristone did not prevent the oxLDL-dependent NOS
inhibition, indicating that the glucocorticoid receptor is
not involved in the suppressive effect of oxLDL.
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Introduction
The early stage of atherosclerosis is characterized
by the infiltration of monocytes in the subendothelial
space. By the unregulated uptake of oxidized low
density lipoproteins (oxLDL) through the scavenger
receptor," these mononuclear cells then accumulate
large amounts of lipids and acquire a so-called
’foamy’ appearance.
Macrophages in general produce numerous media-
tors which play a role in host defence and may
therefore also affect the progression of
atherosclerotic lesions. A recently identified secre-
tion product of activated rodent macrophages is
nitric oxide, which contributes to host defence by its
cytolytic and antimicrobial properties. It is synthe-
sized from t-arginine by an inducible form of nitric
oxide synthase (iNOS), with t-citrulline as a by-
product. The expression of iNOS has been demon-
strated in atherosclerotic vessels.
The effect of foam cell transformation of J774
murine macrophages on the induction of iNOS acti-
vity has been reported. It could be confirmed that
this function is indeed inhibited in cells loaded with
oxLDL but not with acetylated low density
lipoproteins (acLDL). As this indicates that not lipid
accumulation as such, but some constituent ofoxLDL
might exert an inhibitory action on the induction of
iNOS activity, this study was designed to elucidate
the underlying mechanism.
Since the induction of iNOS in macrophages is
also inhibited by glucocorticoids (GC) and
glucocorticoids are synthesized from cholesterol via
oxidative pathways, it was hypothesised that GC-like
products might be formed during the oxidation of
the cholesterol-rich LDL particle. To investigate
whether a GC-like factor in oxLDL might be respon-
sible for the observed inhibition of iNOS activity,
the glucocorticoid receptor (GCR) antagonist
mifepristone was added during lipid loading and
stimulation, thus attempting to reverse the observed
inhibition.
Materials and Methods
Materials: All cell culture media and supplements
were from Gibco Ltd, Paisley, UK. Reagents for the
cholesterol assay were from Boehringer Mannheim
(Mannheim, Germany), reagents for the protein assay
from Pierce (Rockford, IL, USA), sodium nitrite from
Merck (Darmstadt, Germany), tetramethoxypropane
from Aldrich Chemie (Brussels, Belgium), and
Aquacide from Calbiochem (La Jolla, CA, USA).
Interferon-7 (recombinant rat IFN-T) was purchased
from Holland Biotechnology (Leiden, The Nether-
lands). Mifepristone (RU 38 486) was a gift from
Roussel UCLAF (Romainville, France). Lipoprotein
deficient serum (LPDS), low density lipoprotein
(LDL) and acetylated LDL (acLDL) were prepared as
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described previously. All other reagents, lipopoly-
saccharide (LPS, Salmonella typhosa) and dexa-
methasone, were from Sigma Chemical Company
(St. Louis, MO, USA).
LDL oxidation: LDL 4 mg/ml was dialysed for 24 h
against phosphate buffered saline (PBS) to remove
EDTA. Oxidation of LDL 200 lttg/ml was performed in
PBS by addition of CuCl,. (6.4 btM) during 16 h at 37C
and stopped by adding EDTA (200 lttM) and keeping
on ice for 1 h. Before and after oxidation, a sample
was taken for determination of thiobarbituric acid
reactive substances (TBARS) as a measure of lipid
peroxidation. Then the oxLDL solution was dialysed
for 24 h against PBS plus EDTA to remove the Cu
2/
ions and concentrated to +1.5 mg/ml by keeping the
dialysis bag in Aquacide powder for _+ 8 h.
Lipidperoxidation assay: A sample volume of 0.5 ml
was mixed with 2 ml 0.25 M HCl containing 3.75%
thiobarbituric acid and 15% TCA, and boiled for
15 min. After centrifugation at 1500 g for 15 min,
absorbance was read at 532 nm. Results, expressed
as nmol malondialdehyde (MDA) equivalents/mg
protein, are obtained from a standard curve with
tetramethoxypropane, which decomposes to MDA
under the assay conditions.
Culture and lipid loading ofJ774 cells: J774 murine
macrophage-like cells (ATCC, Rockville, MD, USA)
Were maintained in Dulbecco’s modified Eagle me-
dium (DMEM) supplemented with 10% foetal calf
serum (FCS) and antibiotics (penicillin 100 U/ml,
streptomycin 100 lttg/ml). Cells (2 x 106/35 mm dish)
were seeded in 6-well plates to obtain a confluent
monolayer 24 h later. Subsequently, lipid loading
was performed by incubation with oxLDL (200 btg/
ml) or acLDL (100 btg/ml) for 24 h in DMEM supple-
mented with 10% lipoprotein deficient serum and
antibiotics. The amount of total cell protein after
loading with acLDL or oxLDL was 724 _+ 84 l.tg and
777 _+ 148 btg respectively, which is not different from
control cells (690 _+ 37 l.tg), indicating that lipid load-
ing did not result in cell loss (n 4). In some experi-
ments polymyxin B (10 t.tg/ml) was added during
loading.
Determination of total cellular cholesterol and pro-
tein: After lipid loading the monolayers were washed
three times with cold PBS to remove serum proteins
and lipoproteins. Cholesterol extraction was per-
formed in the plate by adding 5 ml hexane:propan-
2-ol (3:2) for I h, followed by a brief wash with 1 ml.
The solvent was evaporated under reduced pressure
and cholesterol and cholesterol esters determined by
an enzymatic assay. Total cell protein was deter-
mined by the bicinchoninic acid (BCA) method. The
wells were exposed to 3 ml trichloroacetic acid (TCA)
5% for 2 h, followed by dissolution of the precipi-
tated proteins in 2 ml 0.1 N NaOH plus 0.5% sodium
dodecyl sulphate. Results are expressed as btg choles-
terol/mg protein and percent esters of total choles-
terol.
Stimulation ofJ774 cells: Control and lipid-laden
monolayers were washed three times with warm
DMEM and fresh medium (DMEM without phenol
red, 400 btM t-arginine, 10% FCS, antibiotics) was
added. Cells were then stimulated with LPS 10 btg/ml
with or without IFN-, 100 U/ml for 48 h.
Determination of nitric oxide synthase activity: NOS
activity was assessed by measuring nitrite, a stable
NO metabolite, and t-citrulline in the cell-free
supernatant 48 h after stimulation. The nitrite assay is
based on the diazotization of sulfanilic acid by NO,
derived from NO at acidic pH. Subsequently,
coupling with N-(1-naphthyl)-ethylenediamine
yields a coloured product that is measured
spectrophotometrically at 540 nm.1 t-Citrulline was
measured with a Biotronik LC 6000 E amino acid
analyser (Biotronok, Maintal, Germany). Results are
expressed as nmoles nitrite and citrulline/mg protein.
The detection limit of both assays is 1 btM.
Effect of dexamethasone and mifepristone on NOS
activity: Dexamethasone 10-5, 10-
and 10.7 M was
added to the control cells together with the stimulus.
The ability of mifepristone, a glucocorticoid receptor
(GCR) antagonist, to prevent the effects of
dexamethasone, was investigated by co-addition
(10-5 and 10-7 M). Mifepristone 10-5 and 10-7 was also
added during lipid loading and stimulation of foam
cells to assess its ability to prevent the inhibitory
effect of oxLDL.
Statistical analysis: Values are expressed as the
mean + S.E.M. of four to five experiments. Differ-
ences between the means were determined by the
Student’s paired t-test. A p-value less than 0.05 was
considered significant.
Results
LDL oxidation: LDL contained very low amounts of
MDA equivalents before oxidation, indicating that
minimal spontaneous oxidation had occurred. Oxi-
dation with CuC12 increased the MDA equivalents 42-
fold, while final dialysing and concentrating resulted
in substantial loss of TBARS (Table 1).
Table 1: LDL oxidation, measured as thiobarbituric acid reactive
substances (TBARS)
LDL TBARS
(nmol MDA equivalents/mg protein)
Before oxidation 1.5 + 0.8 (n= 8)
After oxidation 64.0 + 4.0 (n= 8)
After dialysis 6.9 + 0.7 (n= 6)
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Foam cellformation: The total cholesterol content of
control macrophages was 30+21.tg/mg protein,
94 + 2% was present as free cholesterol. Incubation
ofJ774 cells with acLDL 100 l.tg/ml or oxLDL 200 l.tg/
ml resulted in foam cells with a comparable high
amount of total cholesterol, 101 _+ 10 and 92 _+ 17 l.tg
cholesterol/mg protein respectively. The percentage
of cholesterol esters was 53% and 36% respectively.
Nitrite and citrulline release by unloadedJ774 cells:
Supernatant of unstimulated cells did not contain
measurable amounts of nitrite or citrulline (Fig. 1).
LPS 10 I.tg/ml induced NOS activity, as indicated by
the accumulation of 59_+ 15 nmoles nitrite and
98 _+ 15 nmoles citrulline/mg protein in the 48 h
supernatant. Addition of IFN-y resulted in signifi-
cantly higher production of these two t-arginine
metabolites, especially citrulline. Interferon-y alone
was only a very weak stimulus for NOS induction
(data not shown).
Nitrite and citrulline release by J774 foam cells:
Unstimulated acLDL-laden foam cells did not pro-
duce nitrite or citrulline (Fig. 1). However, in oxLDL-
laden cells NOS activity was induced, resulting in
small amounts of nitrite (13 -+ 4 nmol/mg protein)
and citrulline (12 -+ 5 nmol/mg protein) in the 48 h
supernatant of unstimulated cells.
LPS 10 l.tg/ml induced NOS activity in acLDL-laden
cells to the same extent as in control cells. In oxLDL-
laden cells however, NOS activity was significantly
suppressed, with only 38% of nitrite production and
25% of citrulline production compared to control
cells. This was also observed for the stronger stimu-
lation with both LPS and IFN-T, although the inhibi-
tion was less pronounced (75% of nitrite release and
33% of citrulline release compared to control cells).
Addition of polymyxin B together with oxLDL
during lipid loading did not eliminate the small
induction of NOS activity nor the suppression of LPS
induced activity in these cells (data not shown).
Effect of dexamethasone and mifepristone on NOS
activity in J774 cells: In control cells, addition of
dexamethasone together with LPS 10 t.tg/ml resulted
in dose dependent inhibition of nitrite release (Table
2). The inhibitory effect of dexamethasone was re-
versed in a concentration dependent manner by co-
addition of the glucocorticoid receptor antagonist
mifepristone (Table 2, Fig. 2). Mifepristone did not
affect nitrite production when added alone (data not
shown).
Mifepristone (10-7M and 10-5 M), added during
lipid loading and stimulation of the cells, failed to
antagonize the inhibition of NOS activity in the
oxLDL-laden foam cells (Fig. 2).
Table 2: Effect of dexamethasone and mifepristone on LPS in-
duced nitrite release
Concentration of Control
dexamethasone (M)
Concentration of mifepristone
10-7 M 10-s M
10-7 66 + 3 77 + 2" 89 + 4*
10-
34 + 3 74 + 3" 89 + 4"
10-s 20 + 2 52 + 3" 77 + 2"
Results are expressed as percent of maximal LPS induced nitrite
production S.E.M. (n-- 4).
*p < 0.05, different from dexamethasone alone.
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FIG. 1. Nitrite (A) and citrulline (B) release by J774 control and foam cells. Nitrite and citrulline were measured in the supernatant of control cells ([E]), acLDL-
laden cells () and oxLDL-laden cells (E) after 48 h with or without LPS +/- IFN-7. NS not stimulated. "p < 0.05 vs. control.
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FIG. 2. Mifepristone reverses induced NOS inhibition by dexamethasone
(10 M) () without influencing the suppression by oxLDL (). Control
cells ([) were stimulated with LPS (10 lg/ml) and produced 59 _+ 15 nmol
nitrite/mg protein. Results are expressed as percent of control. "p < 0.05 vs.
no mifepristone added.
Discussion
J774 cells have been used for the study of choles-
terol metabolism and lipoprotein handling
7,11 in
macrophages. They express the scavenger
receptor(s) and thus can take up modified
lipoproteins such as acLDL or oxLDL, eventually
leading to intracellular cholesterol ester accumula-
tion, the hallmark of foam cells. Several authors have
reported the presence of oxLDL in atherosclerotic
lesions,1’a3 whereas acLDL is probably not relevant in
vivo. In vitro, both forms of modified lipoproteins
induce lipid accumulation in J774 cells, and thus
provide an easy-to-use foam cell model. In the
present experiments, oxLDL had to be used in a
higher concentration than acLDL in order to obtain
cells with comparable amounts of total cholesterol
after 24 h. Also, cholesterol esterification is higher in
acLDL-laden cells. These two observations point to
differences in uptake and intracellular processing of
the modified lipoproteins. As total cell protein after
lipid loading was not affected, this procedure proved
to be non-toxic to the macrophages.
In this study NOS activity inJ774 cells was induced
by LPS. NOS metabolizes t-arginine to NO and
citrulline, which both accumulate extracellularly.
Nitric oxide spontaneously converts to the more
stable products nitrite and nitrate, about 60% and
40% respectively, with no conversion from one prod-
uct to the other. 14 Nitric oxide is presumably the main
source of nitrite, whereas citrulline is involved in
more complex biochemical pathways and can also be
derived from t-arginine through the consecutive ac-
tion of arginase and ornithine transcarbamylase. IFN- ,, which on its own was a very weak stimulus for
NOS induction in J774 cells, acted synergistically
with LPS to induce higher NOS activity, as indicated
by the increased release of nitrite and citrulline. This
combination possibly also stimulated the arginase
pathway, since the synergistic effect of IFNq, for
citrulline release was much higher than for nitrite
release. On the other hand, LPS plus IFN-, may have
stimulated the macrophages for production of oxy-
gen radicals, and reaction of superoxide anion and
NO preferentially leads, via peroxynitrite, to nitrate, 15
at the expense of nitrite. In that case, citrulline is a
better parameter of NOS activity than nitrite. Another
explanation could be leakage of intracellular
t-citrulline16 in the supernatant, due to cell death.
In view of these considerations, determination
of both nitrite and citrulline in the cell-free
supernatant seems to be required to evaluate
induced NOS activity.
NOS activity was investigated in J774 foam cells.
AcLDL-laden cells, unstimulated or stimulated, were
not different from control cells with respect to either
nitrite or citrulline release, indicating that lipid accu-
mulation as such did not necessarily alter induced
NOS activity. However, in oxLDL-laden cells, two
changes were observed. First, unstimulated oxLDL-
laden cells already displayed some induced NOS
activity, whereas acLDL-laden cells or control cells
did not. This small induction of NOS activity was
apparently not the result of LPS contamination in the
oxLDL preparation since addition of the LPS-binding
antibiotic polymyxin B did not prevent it. Secondly,
the subsequent stimulation of oxLDL-laden cells with
LPS or LPS plus IFN-, resulted in lower amounts of
released nitrite, compared to acLDL-laden cells or
control cells. This is not due to trapping of NO or
preferential conversion of NO to nitrate by the
oxLDL, since citrulline decreased as well. It is not
clear from the present experiments whether the in-
duction of the NOS gene, the activity of the NOS
enzyme or the availability of t-arginine is decreased.
It has been reported that oxLDL inhibits other LPS
inducible gene products such as TNF0,
17 IL-I and
,18 IL_68 and PDGF. 19’2 In these studies, mRNAs
were suppressed, suggesting that inhibition took
place at the level of transcription or signal
transduction. The observation that oxLDL inhibits the
induction of several cytokines and NOS points to a
more general mechanism of action. Since
glucocorticoids also inhibit the induction of many
LPS inducible genes,’ it was speculated that a com-
mon mechanism might be responsible.
It could be that cholesterol oxidation products
with glucocorticoid-like activity are formed during
the oxidation of LDL. However, although the GC
receptor antagonist mifepristone was clearly capable
of partially reversing dexamethasone mediated NOS
inhibition, it was unable to prevent the inhibitory
action of oxLDL on NOS activity.
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Other cellular events initiated by oxLDL may be
involved. For instance, it has been reported that
oxLDL increases arachidonate metabolism to
prostaglandin E (PGE2) and PGI2,
22 and some of
these products may inhibit NOS induction. 23
TNFot has been reported to be an autocrine media-
tor in NOS induction in murine macrophages. 24,25 In
oxLDL-treated cells, TNFot expression after stimula-
tion is decreased, 17 which could lead to decreased
NOS induction. However, oxLDL did not induce
TNFot transcription
1: in unstimulated murine cells,
whereas NOS induction was observed. Although
TNF expression and NO production can occur in-
dependently, the possibility that the oxLDL-mediated
NOS inhibition is TNF-dependent remains open.
In conclusion, the study demonstrated that induc-
tion ofNOS activity is specifically inhibited in oxLDL-
and not in acLDL-laden foam cells. The mechanism
of the observed inhibition is not clear at this moment,
but a glucocorticoid-like action of oxLDL does not
seem to be involved in view of the failure of the GCR
antagonist to prevent the suppression.
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